Abstract:Background Sudden cardiac death (SCD) is the most feared complications of hypertrophic cardiomyopathy (HCM). Indications for implantable cardioverter defibrillators (ICDs) in HCM patients are defined in the ACC/AHA guidelines. We sought to assess predictors of fatal arrythmias as defined by appropriate ICD discharges and the additive role of late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) to further assist in risk stratification. Methods Patients with HCM followed at a tertiary referral center who underwent CMR and ICD implantation between 2002-2022 were analyzed. Predictors of appropriate device shocks were assessed based on risk factors utilized by ACC/AHA guidelines. Univariable cox regression was used to quantify the association between baseline variables and shock rate. Bivariable cox regression with a term for interaction between presence of LGE >10% and ICD indication was then conducted. Results 134 patients with left ventricular ejection fraction >50% were included, of whom 114 had available LGE quantification on CMR. Median follow up time was 3.7 years. The strongest predictor of receiving appropriate ICD shock was an ICD placement as secondary prevention (10 patients) [HR 8.64 (3.48 to 21.48)]. The primary prevention indication most strongly associated with early ICD shock was presence of ventricular arrythmias on ambulatory monitoring [HR 2.03 (0.91 to 4.57)] (Table 1). Female sex was protective (HR: 0.21). This study did not find an increased risk of appropriate ICD discharge for primary prevention indications including syncope, family history of SCD, or massive hypertrophy, possibly related to sample size and follow-up duration. However, examination of stratum specific rates strongly supports effect modification by LGE. There was strong evidence for an exponential synergistic interaction between LGE burden >10% and both syncope (interaction term 5.5) and apical pouch/aneurysm (interaction term 4.63) (Table 2). Conclusions SCD risk stratification and ICD implantation decision-making remains complex in HCM. Recognizing the synergistic effects of LGE on traditional risk factors for appropriate ICD discharge may enhance clinical judgment for ICD implantation. Further studies are needed to assess how LGE noted on CMR and other primary prevention indications for an ICD in HCM patients might interact.

B-PO03-165 MEAN SCAR ENTROPY PREDICTS VENTRICULAR ARRHYTHMIAS EVENTS IN HYPERTROPHIC CARDIOMYOPATHY USING LATE GADOLINIUM ENHANCEMENT CARDIAC MAGNETIC RESONANCE

Mean Scar Entropy by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Associated With Ventricular Arrhythmias Events in Hypertrophic Cardiomyopathy

Relation of Late Gadolinium Enhancement in Cardiac Magnetic Resonance on the Diastolic Volume Recovery of Left Ventricle with Hypertrophic Cardiomyopathy.

Relation Of Late Gadolinium Enhancement In Cardiac Magnetic Resonance On The Diastolic Volume Recovery Of Left Ventricle With Hypertrophic Cardiomyopathy (Vol 6, Pg 988, 2014)

[Value of Myocardial Scar in Predicting Malignant Ventricular Arrhythmia in Patients with Chronic Myocardial Infarction].

Evaluation of left ventricular myocardial strain of patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients

Predictive value of cardiac magnetic resonance imaging for fatal arrhythmias in structural and nonstructural heart diseases

Relationship between Extension or Texture Features of Late Gadolinium Enhancement and Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy

Impact of Cardiac Magnetic Resonance to Arrhythmic Risk Stratification in Nonischemic Cardiomyopathy

Late gadolinium enhancement on cardiac MRI: A systematic review and meta-analysis of prognosis across cardiomyopathies

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography

Late gadolinium enhancement entropy as a new measure of myocardial tissue heterogeneity for prediction of adverse cardiac events in patients with hypertrophic cardiomyopathy

The Association Between Late Gadolinium Enhancement by Cardiac Magnetic Resonance and Ventricular Arrhythmia in Patients With Mitral Valve Prolapse: A Systematic Review and Meta-Analysis

Cardiac magnetic resonance imaging T1 mapping and late gadolinium enhancement entropy: Prognostic value in patients with systemic sclerosis

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis

Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes

The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast‐enhanced magnetic resonance study

Combined right and left ventricular mechanical dispersion enhance the arrhythmic risk stratification in hypertrophic cardiomyopathy